1. Home
  2. PRPL vs GNLX Comparison

PRPL vs GNLX Comparison

Compare PRPL & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPL
  • GNLX
  • Stock Information
  • Founded
  • PRPL 2010
  • GNLX 2001
  • Country
  • PRPL United States
  • GNLX United States
  • Employees
  • PRPL N/A
  • GNLX N/A
  • Industry
  • PRPL Home Furnishings
  • GNLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRPL Consumer Discretionary
  • GNLX Health Care
  • Exchange
  • PRPL Nasdaq
  • GNLX Nasdaq
  • Market Cap
  • PRPL 90.3M
  • GNLX 85.0M
  • IPO Year
  • PRPL N/A
  • GNLX 2023
  • Fundamental
  • Price
  • PRPL $1.04
  • GNLX $5.34
  • Analyst Decision
  • PRPL Buy
  • GNLX Strong Buy
  • Analyst Count
  • PRPL 3
  • GNLX 4
  • Target Price
  • PRPL $1.70
  • GNLX $18.25
  • AVG Volume (30 Days)
  • PRPL 561.8K
  • GNLX 396.9K
  • Earning Date
  • PRPL 03-11-2025
  • GNLX 03-31-2025
  • Dividend Yield
  • PRPL N/A
  • GNLX N/A
  • EPS Growth
  • PRPL N/A
  • GNLX N/A
  • EPS
  • PRPL N/A
  • GNLX N/A
  • Revenue
  • PRPL $504,838,000.00
  • GNLX $8,000.00
  • Revenue This Year
  • PRPL N/A
  • GNLX N/A
  • Revenue Next Year
  • PRPL $1.83
  • GNLX N/A
  • P/E Ratio
  • PRPL N/A
  • GNLX N/A
  • Revenue Growth
  • PRPL N/A
  • GNLX N/A
  • 52 Week Low
  • PRPL $0.75
  • GNLX $1.60
  • 52 Week High
  • PRPL $2.33
  • GNLX $8.67
  • Technical
  • Relative Strength Index (RSI)
  • PRPL 50.04
  • GNLX 72.84
  • Support Level
  • PRPL $0.99
  • GNLX $4.10
  • Resistance Level
  • PRPL $1.09
  • GNLX $5.89
  • Average True Range (ATR)
  • PRPL 0.08
  • GNLX 0.54
  • MACD
  • PRPL -0.02
  • GNLX 0.14
  • Stochastic Oscillator
  • PRPL 23.64
  • GNLX 79.70

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

Share on Social Networks: